Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 13/20 | 0.44 |
| ▸ | MAOA | P21397 | 8/20 | 0.43 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 3/20 | 0.40 |
| ▸ | CA4 | P22748 | 3/20 | 0.40 |
| ▸ | CA9 | Q16790 | 3/20 | 0.40 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13301435 | 0.83 | MAOB (0.46) | MAOBMAOACYP1A1CYP1A2CA12 | |
| SCHEMBL20530588 | 0.82 | MAOB (0.46) | MAOBMAOACYP1A1CYP1A2CA12 | |
| SCHEMBL20530579 | 0.82 | NQO2 (0.50) | MAOBMAOACYP1A1CYP1A2CA12 | |
| SCHEMBL19038911 | 0.82 | CYP3A4 (0.49) | MAOBMAOACA12CA4CA9 | |
| SCHEMBL19038939 | 0.80 | MAOB (0.53) | MAOBMAOAACHEGSTP1MAPT | |
| SCHEMBL2204213 | 0.79 | HTR1B (0.55) | MAOBCYP1A2 | |
| SCHEMBL30000708 | 0.79 | HTR1B (0.55) | MAOBCYP1A2 | |
| SCHEMBL10518935 | 0.78 | MAOB (0.49) | MAOBMAOACYP1A1CYP1A2MAPT | |
| Ammonia Solution, Strong SCHEMBL27736316 | 0.77 | HTR1B (0.53) | MAOBCYP1A2 | |
| SCHEMBL9043883 | 0.77 | CA12 (0.57) | MAOBMAOACA12CA4CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10444628-B2 | Compound for forming organic film, composition for forming organic film, method for forming organic film, and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2019-10-15 | — | — | US | disclosed |
| US-20170184968-A1 | COMPOUND FOR FORMING ORGANIC FILM, COMPOSITION FOR FORMING ORGANIC FILM, METHOD FOR FORMING ORGANIC FILM, AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-20170184968-A1 | COMPOUND FOR FORMING ORGANIC FILM, COMPOSITION FOR FORMING ORGANIC FILM, METHOD FOR FORMING ORGANIC FILM, AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
| US-20170183531-A1 | COMPOUND FOR FORMING ORGANIC FILM, COMPOSITION FOR FORMING ORGANIC FILM, METHOD FOR FORMING ORGANIC FILM, AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10444628-B2 | Compound for forming organic film, composition for forming organic film, method for forming organic film, and patterning process | CHRM1, OR10J3, MYB | MAOB 383/4885MAOA 317/4885CYP1A1 56/4885 |
| US-20170184968-A1 | COMPOUND FOR FORMING ORGANIC FILM, COMPOSITION FOR FORMING ORGANIC FILM, METHOD FOR FORMING ORGANIC FILM, AND PATTERNING PROCESS | CHRM1, MLX, OR10J3 | MAOB 577/4885MAOA 409/4885CYP1A1 74/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.